Bioethics.com
Nanotechnology wonder material (no, it’s not graphene) to tackle environmental challenges
A new wonder material that can generate hydrogen, produce clean water and even create energy. (Nanowerk)
Three-person IVF moves closer in UK
The Human Fertilisation and Embryology Authority (HFEA) has advised the government that there is no evidence the advanced forms of IVF were unsafe. The fertility regulator’s public consultation also showed “general support” for the idea as the benefits outweighed the risks. (BBC)
How are abortions counted?
According to China’s health ministry, 336 million abortions have been performed since the country instituted its one-child policy in 1971. How do researchers count abortions? (Slate)
Genetics may be tied to breast cancer risk in unexpected ways
Genetic testing may help identify women at risk for certain types of breast cancer, according to a new study. (U.S. News and World Report)
President’s Bioethics Commission releases report on pediactric medical countermeasure research
In a report released today, the Presidential Commission for the Study of Bioethical Issues concluded that the federal government would have to take multiple steps before anthrax vaccine trials with children could be ethically considered. (Eurekalert)
Stem cell research could expand clinical use of regenerative human cells
Research led by a biology professor in the School of Science at Indiana University-Purdue University Indianapolis (IUPUI) has uncovered a method to produce retinal cells from regenerative human stem cells without the use of animal products, proteins or other foreign substances, which historically have limited the application of stem cells to treat disease and other human developmental disorders. (Medical Xpress)
Abortion doctor’s murder trial opens
In opening statements in court on Monday, prosecutors charged that a doctor who operated a women’s health clinic here killed seven viable fetuses by plunging scissors into their necks and “snipping” their spinal cords and was also responsible for the death of a pregnant woman in his care. (New York Times)
No sons linked to lower contraception use in Nepal
While poverty and under-education continue to dampen contraception use in Nepal, exacerbating the country’s efforts to reduce maternal and child mortality rates, researchers say another, more surprising factor may be more intractable: Deeply held cultural preferences for sons over daughters. (Science Daily)
Pediatric neuroenhancement
This Ethics, Law, and Humanities Committee position paper, endorsed by the American Academy of Neurology, Child Neurology Society, and American Neurological Association, focuses on various implications of pediatric neuroenhancement and outlines discussion points in responding to neuroenhancement requests from parents or adolescents. (Neurology)
Mayo Clinic to hold trial for BrainStorm’s ALS stem cell therapy
BrainStorm Cell Therapeutics said the Mayo Clinic in Minnesota has agreed to conduct a clinical trial of the company’s adult stem cell treatment for ALS. (Reuters)
Third-party blood stem cell transplantation as a factor to impact on poor graft function
Bone marrow-derived mesenchymal stem cells from third party donors found effective, safe in treating PGF. (Eurekalert)
DATA at a distance: Thoughts on ‘digital public health’
Today, our body temperature can be scanned from a distance quickly and simply. For a busy Mom with a sick child, this is a great idea. Just pointing a sensor at a spot of skin and obtaining an ‘instant’ reading is a real advance from the intrusive glass thermometers and touch scanners of yesterday. (Forbes)
Surrogate pregnancies on rise despite cost hurdles
Margaret DiSantis always wanted a child. But the Chicago advertising executive never expected she would have to sell her house, drop out of business school and move back in with her parents to tackle costs associated with hiring the surrogate mother who delivered a healthy baby girl on her behalf earlier this year. (Reuters)
A cancer gene therapy activated by a pill
A unique new cancer treatment uses gene therapy to induce a cancer-fighting immune response whose intensity can then be controlled with a pill. The combination could help tailor treatment to a patient’s individual response. (MIT Technology Review)
New nanotechnology research turns brain tumors blue
In an article published this week in the journal Drug Delivery and Translational Research, researchers from Children’s Healthcare of Atlanta and the Georgia Institute of Technology have reported the development of a technique that assists in identifying tumors from normal brain tissue during surgery by staining tumor cells blue. (Medical Xpress)
Event: Third National Conference on Genetics, Ethics, and the Law
University of Virgina law and medical schools, the American Society of Human Genetics, and the National Society of Genetic Counselors
Third National Conference on Genetics, Ethics, and the Law
May 22-23, 2013
Charlottesville, VA
For more information and registration, see University of Virginia School of Law.
Pregnancy after 50: Using egg, embryo donations to extend a woman’s reproductive life
Healthy postmenopausal women shouldn’t be discouraged from pursuing pregnancy using donor eggs or embryos, one of the world’s largest organizations of reproductive medicine says. (The Montreal Gazette)
Bioethics researchers support use of cognitive enhancers
Leading bioethics researchers at a discussion forum have voiced their support for society to accept the use of drugs that enhance cognition. (BMJ, by subscription only)
NHS bad practice warnings ‘Ignored by government,’ public health expert Sir Brian Jarman Claims
Government ministers and the NHS ignored warnings about persistently high death rates in hospitals which could have claimed the lives of up to 20,000 patients, a top health adviser has said. (Huffington Post)
North Dakota Senate approves “heartbeat” abortion ban
The North Dakota Senate approved what would be the most restrictive abortion law in the United States on Friday, a measure banning the procedure in most cases once a fetal heartbeat can be detected, as early as six weeks. (Reuters)






